| 000 | 01169 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250511151334.0 | ||
| 264 | 0 | _c19760706 | |
| 008 | 197607s 0 0 eng d | ||
| 022 | _a0020-8272 | ||
| 024 | 7 |
_a10.1159/000468208 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPöldinger, W | |
| 245 | 0 | 0 |
_aApplication of the neuroleptic pimozide (ORAP-R 6238) for tranquilizer indications in a controlled study. _h[electronic resource] |
| 260 |
_bInternational pharmacopsychiatry _c1976 |
||
| 300 |
_a16-24 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnxiety Disorders _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDiazepam _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPimozide _xadverse effects |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aPsychophysiologic Disorders _xdrug therapy |
| 773 | 0 |
_tInternational pharmacopsychiatry _gvol. 11 _gno. 1 _gp. 16-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000468208 _zAvailable from publisher's website |
| 999 |
_c788256 _d788256 |
||